YWY-26373-44541
1 vaccination
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 281 / NC
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Registered in v-safe
-
2021-03-31
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-31
- 2021-04-01
- 2021-04-03
- 2021-04-05
- 2021-04-11
-
2021-07-02
Survey response — 3 months, dose 1MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnant · Healthcare visit (other): Prenatal visitsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-02
Report sent to call center — 3 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-07
- 2022-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-02 | Unsuccessful |
Free text
Release 9 — 3 months, dose 1
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release